Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021

por Konu, Yao Rodion, Gbeasor-Komlanvi, Fifonsi Adjidossi, Yerima, Mouhoudine, Sadio, Arnold Junior, Tchankoni, Martin Kouame, Zida-Compaore, Wendpouire Ida Carine, Nayo-Apetsianyi, Josée, Afanvi, Kossivi Agbélénko, Agoro, Sibabe, Salou, Mounerou, Landoh, Dadja Essoya, Nyansa, Atany B., Boko, Essohanam, Mijiyawa, Moustafa, Ekouevi, Didier Koumavi
Publicado 2021

Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020

por Halatoko, Wemboo Afiwa, Konu, Yao Rodion, Gbeasor-Komlanvi, Fifonsi Adjidossi, Sadio, Arnold Junior, Tchankoni, Martin Kouame, Komlanvi, Koffi Segbeaya, Salou, Mounerou, Dorkenoo, Ameyo Monique, Maman, Issaka, Agbobli, Amétépé, Wateba, Majesté Ihou, Adjoh, Komi Séraphin, Goeh-Akue, Edem, Kao, Yem-bla, Kpeto, Innocent, Pana, Paul, Kinde-Sossou, Rebecca, Tamekloe, Agbeko, Nayo-Apétsianyi, Josée, Assane, Simon-Pierre Hamadi, Prine-David, Mireille, Awoussi, Sossinou Marcel, Djibril, Mohaman, Mijiyawa, Moustafa, Dagnra, Anoumou Claver, Ekouevi, Didier Koumavi
Publicado 2020